References

  1. Kalatzis V, Antignac C. Cystinosis: from gene to disease. Nephrol Dial Transplant. 2002; 17(11):1883-1886. PubMed | Google Scholar

  2. Soliman NA, Elmonem MA, van den Heuvel L et al. Mutational Spectrum of the CTNS Gene in Egyptian Patients with Nephropathic Cystinosis. JIMD Rep. 2014;14:87-97. PubMed | Google Scholar

  3. Ivanova E, De Leo MG, De Matteis MA, Levtchenko E. Cystinosis: clinical presentation, pathogenesis and treatment. Pediatr Endocrinol Rev. 2014 ;12 (1):176-84. PubMed | Google Scholar

  4. Soliman AN, El-Baroudy R, Rizk A et al. Nephropathic Cystinosis in Children: an overlooked disease. Saudi J Kidney Dis Transpl. 2009; 20 (3):436-42. PubMed | Google Scholar

  5. Pache de Faria Guimaraes L, Seguro AC, Shimizu MH et al. N-acetyl-cysteine is associated to renal function improvement in patients with nephropathic cystinosis. Pediatr Nephrol. 2014;29(6):1097-102. PubMed | Google Scholar

  6. Al Haggar M. Cystinosis as a lysosomal storage disease with multiple mutant alleles: phenotypic-genotypic correlations. World J Nephrol. 2013;2(4):94-102. PubMed | Google Scholar

  7. Gultekingil Keser A, Topaloglu R, Bilginer Y, Besbas N. Long-term endocrinologic complications of cystinosis. Minerva Pediatr. 2014; 66(2):123-30. PubMed | Google Scholar

  8. Emma F, Nesterova G, Langman C et al. Nephropathic cystinosis: an international consensus document. Nephrol Dial Transplant. 2014; 29 (4):87-94. PubMed | Google Scholar

  9. Galina Nesterova, William Gahl A. Cystinosis: the evolution of a treatable disease. Pediatr Nephrol. 2013; 28(1):51-59. PubMed | Google Scholar

  10. Nesterova G, Gahl W. Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol. 2008; 23(6):863-878. PubMed | Google Scholar

  11. Cherqui S. Cysteamine therapy: a treatment for cystinosis, not a cure. Kidney Int. 2012; 81(2): 127-129. PubMed | Google Scholar

  12. Ariceta G, Lara E, Camacho JA et al. Cysteamine (Cystagon®) adherence in patients with cystinosis in Spain: successful in children and a challenge in adolescents and adults. Nephrol Dial Transplant. 2015; 30(3):475-80. PubMed | Google Scholar

  13. Gahl WA, Balog JZ, Kleta R. Nephropathic Cystinosis in adults: natural history and effects of oral cysteamine therapy. Ann Intern Med. 2007; 147(4):242-50. PubMed | Google Scholar

  14. Brodin-Sartorius A, Tęte M-J, Niaudet P et al. Cysteamine therapy delays the progression of nephropathic cystinosis in late adolescents and adults. Kidney Int. 2012; 81(2):179-189. PubMed | Google Scholar

  15. Bertholet-Thomas A, Bacchetta J, Tasic V et al. Nephropathic Cystinosis - A Gap between Developing and Developed Nations. N Engl J Med. 2014; 370(14):1366-7. PubMed | Google Scholar

  16. Spicer RA, Clayton PA, McTaggart SJ, Zhang GY, Alexander SI. Patient and graft survival following kidney transplantation in recipients with cystinosis: a cohort study. Am J Kidney Dis. 2015 ;65(1):172-3. PubMed | Google Scholar